BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

311 related articles for article (PubMed ID: 15274621)

  • 1. Thermodynamic evaluation of a covalently bonded transition state analogue inhibitor: inhibition of beta-lactamases by phosphonates.
    Nagarajan R; Pratt RF
    Biochemistry; 2004 Aug; 43(30):9664-73. PubMed ID: 15274621
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Kinetics of turnover of cefotaxime by the Enterobacter cloacae P99 and GCl beta-lactamases: two free enzyme forms of the P99 beta-lactamase detected by a combination of pre- and post-steady state kinetics.
    Kumar S; Adediran SA; Nukaga M; Pratt RF
    Biochemistry; 2004 Mar; 43(9):2664-72. PubMed ID: 14992604
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Beta-secondary and solvent deuterium kinetic isotope effects on catalysis by the Streptomyces R61 DD-peptidase: comparisons with a structurally similar class C beta-lactamase.
    Adediran SA; Pratt RF
    Biochemistry; 1999 Feb; 38(5):1469-77. PubMed ID: 9931012
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Different transition-state structures for the reactions of beta-lactams and analogous beta-sultams with serine beta-lactamases.
    Tsang WY; Ahmed N; Hinchliffe PS; Wood JM; Harding LP; Laws AP; Page MI
    J Am Chem Soc; 2005 Dec; 127(49):17556-64. PubMed ID: 16332108
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inhibition of beta-lactamases by monocyclic acyl phosph(on)ates.
    Kaur K; Adediran SA; Lan MJ; Pratt RF
    Biochemistry; 2003 Feb; 42(6):1529-36. PubMed ID: 12578365
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Structure of a phosphonate-inhibited beta-lactamase. An analog of the tetrahedral transition state/intermediate of beta-lactam hydrolysis.
    Chen CC; Rahil J; Pratt RF; Herzberg O
    J Mol Biol; 1993 Nov; 234(1):165-78. PubMed ID: 8230196
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Beta-secondary and solvent deuterium kinetic isotope effects on beta-lactamase catalysis.
    Adediran SA; Deraniyagala SA; Xu Y; Pratt RF
    Biochemistry; 1996 Mar; 35(11):3604-13. PubMed ID: 8639512
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Crystal structure of an acylation transition-state analog of the TEM-1 beta-lactamase. Mechanistic implications for class A beta-lactamases.
    Maveyraud L; Pratt RF; Samama JP
    Biochemistry; 1998 Feb; 37(8):2622-8. PubMed ID: 9485412
    [TBL] [Abstract][Full Text] [Related]  

  • 9. On the importance of a methyl group in beta-lactamase evolution: free energy profiles and molecular modeling.
    Bernstein NJ; Pratt RF
    Biochemistry; 1999 Aug; 38(32):10499-510. PubMed ID: 10441146
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Three-dimensional structure of AmpC beta-lactamase from Escherichia coli bound to a transition-state analogue: possible implications for the oxyanion hypothesis and for inhibitor design.
    Usher KC; Blaszczak LC; Weston GS; Shoichet BK; Remington SJ
    Biochemistry; 1998 Nov; 37(46):16082-92. PubMed ID: 9819201
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The D-methyl group in beta-lactamase evolution: evidence from the Y221G and GC1 mutants of the class C beta-lactamase of Enterobacter cloacae P99.
    Adediran SA; Zhang Z; Nukaga M; Palzkill T; Pratt RF
    Biochemistry; 2005 May; 44(20):7543-52. PubMed ID: 15895997
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inhibition of serine beta-lactamases by vanadate-catechol complexes.
    Adediran SA; Pratt RF
    Biochemistry; 2008 Sep; 47(36):9467-74. PubMed ID: 18702503
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The crystal structure of phosphonate-inhibited D-Ala-D-Ala peptidase reveals an analogue of a tetrahedral transition state.
    Silvaggi NR; Anderson JW; Brinsmade SR; Pratt RF; Kelly JA
    Biochemistry; 2003 Feb; 42(5):1199-208. PubMed ID: 12564922
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Kinetics and mechanism of the hydrolysis of depsipeptides catalyzed by the beta-lactamase of Enterobacter cloacae P99.
    Xu Y; Soto G; Hirsch KR; Pratt RF
    Biochemistry; 1996 Mar; 35(11):3595-603. PubMed ID: 8639511
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Chromophoric spin-labeled beta-lactam antibiotics for ENDOR structural characterization of reaction intermediates of class A and class C beta-lactamases.
    Mustafi D; Hofer JE; Huang W; Palzkill T; Makinen MW
    Spectrochim Acta A Mol Biomol Spectrosc; 2004 May; 60(6):1279-89. PubMed ID: 15134725
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Beta-ketophosphonates as beta-lactamase inhibitors: Intramolecular cooperativity between the hydrophobic subsites of a class D beta-lactamase.
    Perumal SK; Adediran SA; Pratt RF
    Bioorg Med Chem; 2008 Jul; 16(14):6987-94. PubMed ID: 18572409
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inhibition of class A and class C beta-lactamases by penems: crystallographic structures of a novel 1,4-thiazepine intermediate.
    Nukaga M; Abe T; Venkatesan AM; Mansour TS; Bonomo RA; Knox JR
    Biochemistry; 2003 Nov; 42(45):13152-9. PubMed ID: 14609325
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mechanism of reaction of acyl phosph(on)ates with the beta-lactamase of Enterobacter cloacae P99.
    Kaur K; Pratt RF
    Biochemistry; 2001 Apr; 40(15):4610-21. PubMed ID: 11294628
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Kinetic and structural consequences of the leaving group in substrates of a class C beta-lactamase.
    Ahn YM; Pratt RF
    Bioorg Med Chem; 2004 Mar; 12(6):1537-42. PubMed ID: 15018927
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mechanism of inhibition of the class C beta-lactamase of Enterobacter cloacae P99 by phosphonate monoesters.
    Rahil J; Pratt RF
    Biochemistry; 1992 Jun; 31(25):5869-78. PubMed ID: 1610830
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.